Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | TYR | P14679 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | GMNN | O75496 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzenethiol SCHEMBL9678426 | 0.84 | NR1H2 (0.37) | NR1H2CYP3A4CA12CA1CA2 | |
| SCHEMBL19865715 | 0.80 | NR1H2 (0.46) | NR1H2CYP3A4HSD17B10CA12CA1 | |
| SCHEMBL10835149 | 0.80 | CYP3A4 (0.59) | CYP3A4HSD17B10ALOX15HIF1AESR2 | |
| SCHEMBL583468 | 0.78 | NR1H2 (0.55) | NR1H2CYP3A4HSD17B10CA12CA1 | |
| Methoxymethane SCHEMBL10979307 | 0.76 | NR1H2 (0.78) | NR1H2CYP3A4HSD17B10CA12CA1 | |
| SCHEMBL15097492 | 0.76 | CYP1A1 (0.45) | ALOX15LMNAALDH1A1SLC6A2SLC6A4 | |
| SCHEMBL8265860 | 0.76 | ACHE (0.44) | HSD17B10CA1CA2CA9MEN1 | |
| SCHEMBL7523445 | 0.75 | NR1H2 (0.41) | NR1H2CYP3A4HSD17B10CA12CA1 | |
| SCHEMBL2303866 | 0.74 | — | — | |
| SCHEMBL22631937 | 0.74 | CYP2A6 (0.42) | MEN1KMT2AALOX15LMNAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1192178-A2 | RUFOMYCINS AND DERIVATIVES THEREOF USEFUL AS INHIBITORS OF MULTI-DRUG RESISTANCE ASSOCIATED PROTEIN-1 (MRP-1) | ELI LILLY AND COMPANY (US) | 2002-04-03 | — | — | EP | claimed |
| WO-2000078795-A2 | RUFOMYCINS AND DERIVATIVES THEREOF USEFUL AS INHIBITORS OF MULTI-DRUG RESISTANCE ASSOCIATED PROTEIN-1 (MRP-1) | ELI LILLY AND COMPANY (US) | 2000-12-28 | — | — | WO | claimed |
| US-5805326-A | Optical limiter structure and method | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1998-09-08 | — | — | US | claimed |
| US-11945802-B2 | Additive for imparting ultraviolet absorbency and/or high refractive index to matrix, and resin member using same | MIYOSHI OIL & FAT CO., LTD. (JP) | 2024-04-02 | — | — | US | disclosed |
| EP-4282922-A2 | ADDITIVE FOR IMPARTING ULTRAVIOLET ABSORPTIVITY AND/OR HIGH REFRACTIVE INDEX TO MATRIX, AND RESIN MEMBER USING SAME | Miyoshi Oil & Fat Co., Ltd. (JP) | 2023-11-29 | — | — | EP | disclosed |
| WO-2023190836-A1 | ADDITIVE FOR RESIN, METHOD FOR PRODUCING SAME, AND METHOD FOR SUPPRESSING COLORATION OF RESIN | ミヨシ油脂株式会社 | 2023-10-05 | — | — | WO | disclosed |
| EP-3178898-B1 | ADDITIVE FOR IMPARTING ULTRAVIOLET ABSORPTIVITY AND/OR HIGH REFRACTIVE INDEX TO MATRIX, AND RESIN MEMBER USING SAME | MIYOSHI YUSHI KK (JP) | 2023-10-04 | — | — | EP | disclosed |
| CN-111808320-B | Additive for imparting ultraviolet absorbing ability and/or high refractive index to substrate, and resin member using same | 三吉油脂株式会社 | 2023-02-28 | — | — | CN | disclosed |
| EP-3208285-B2 | PRODUCTION METHOD OF AN ETHYLENE AND/OR ALPHA-OLEFIN-BASED IONOMER | JAPAN POLYETHYLENE CORP (JP) | 2023-01-25 | — | — | EP | disclosed |
| CN-115584055-A | Additive for imparting ultraviolet absorbing ability and/or high refractive index to substrate and resin member using same | 三吉油脂株式会社 | 2023-01-10 | — | — | CN | disclosed |
| US-11370780-B2 | Additive for imparting ultraviolet absorbency and/or high refractive index to matrix, and resin member using same | MIYOSHI OIL & FAT CO., LTD. (JP) | 2022-06-28 | — | — | US | disclosed |
| US-6204273-B1 | TREATMENT OF ANDROGENIC SENSITIVE DISORDERS SUCH AS ACNE VULGARIS, SEBORRHEA, FEMALE HIRSUTISM, MALE PATTERN BALDNESS, AND BENIGN PROSTATIC HYPERPLASIA. | MERCK & CO., INC. | 2001-03-20 | — | — | US | disclosed |
| EP-0724592-B1 | 16-SUBSTITUTED-4-AZA-ANDROSTANE 5-ALPHA-REDUCTASE ISOZYME 1 INHIBITORS | MERCK & CO INC (US) | 1999-01-07 | — | — | EP | disclosed |
| US-5805326-A | Optical limiter structure and method | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1998-09-08 | — | — | US | disclosed |
| US-5739137-A | 16-substituted-4-aza-3-oxo-androstane as 5-alpha-reductase isozyme 1 inhibitors | MERCK & CO., INC. (US) | 1998-04-14 | — | — | US | disclosed |
| US-5719158-A | 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors | MERCK & CO., INC. (US) | 1998-02-17 | — | — | US | disclosed |
| EP-0393574-A2 | Hexitol derivatives | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1990-10-24 | — | — | EP | disclosed |
| EP-0285564-A1 | Antistatic and electrically conductive polymers and moulding compositions | CIBA-GEIGY AG (CH) | 1988-10-05 | — | — | EP | disclosed |
| EP-0099303-B1 | BENZOTHIOPYRANOPYRIDINONES AND THEIR SALTS, THEIR PREPARATION AND USE AS MEDICAMENTS, AND COMPOSITIONS CONTAINING THEM | ROUSSEL-UCLAF (FR) | 1987-08-19 | — | — | EP | disclosed |
| EP-0154495-A2 | Improvements in or relating to thioether macrolide derivatives | Omura, Satoshi (JP) | 1985-09-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11945802-B2 | Additive for imparting ultraviolet absorbency and/or high refractive index to matrix, and resin member using same | INTS9, MMS19, F12 | NR1H2 2791/4885CYP3A4 3535/4885HSD17B10 2873/4885 |
| US-11370780-B2 | Additive for imparting ultraviolet absorbency and/or high refractive index to matrix, and resin member using same | MMS19, INTS9, SRRM2 | NR1H2 1671/4885CYP3A4 3136/4885HSD17B10 2196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.